Back to Search Start Over

Etiology, Risk Factors, and Management of Asherman Syndrome.

Authors :
Khan Z
Source :
Obstetrics and gynecology [Obstet Gynecol] 2023 Sep 01; Vol. 142 (3), pp. 543-554. Date of Electronic Publication: 2023 Jul 27.
Publication Year :
2023

Abstract

Asherman syndrome is characterized by a triad of symptoms including pain, menstrual abnormalities, and infertility and is a result of intrauterine scar tissue after instrumentation of a gravid uterus. Saline sonohysterogram is typically the most sensitive diagnostic tool; however, hysteroscopy is the criterion standard for diagnosis. Treatment includes hysteroscopic-guided lysis of adhesion, with restoration of the anatomy of the uterine cavity. Several modalities are used in an attempt to reduce the reformation of scar tissue after surgery; however, there is no consensus on the ideal method. Stem cells and platelet-rich plasma are being explored as means of regenerative therapy for the endometrium, but data remain limited. At present, most individuals can have restoration of menstrual function; however, lower pregnancy rates and obstetric complications are not uncommon. These complications are worse for patients with a higher grade of disease. Efforts are needed in standardizing classification, reducing uterine instrumentation of the gravid uterus, and referring patients to health care professionals with clinical expertise in this area.<br />Competing Interests: Financial Disclosure The author did not report any potential conflicts of interest.<br /> (Copyright © 2023 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.)

Details

Language :
English
ISSN :
1873-233X
Volume :
142
Issue :
3
Database :
MEDLINE
Journal :
Obstetrics and gynecology
Publication Type :
Academic Journal
Accession number :
37490750
Full Text :
https://doi.org/10.1097/AOG.0000000000005309